Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.45 |
| ▸ | MGLL | Q99685 | 1/20 | 0.45 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.45 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.44 |
| ▸ | CDC25B | P30305 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5793190 | 1.00 | ALDH1A1 (0.58) | ALDH1A1MAPK1L3MBTL1EPHX2TDP1 | |
| SCHEMBL19828807 | 1.00 | ALDH1A1 (0.58) | ALDH1A1MAPK1L3MBTL1EPHX2TDP1 | |
| SCHEMBL7096279 | 1.00 | ALDH1A1 (0.58) | ALDH1A1MAPK1L3MBTL1EPHX2TDP1 | |
| SCHEMBL905734 | 1.00 | ALDH1A1 (0.58) | ALDH1A1MAPK1L3MBTL1EPHX2TDP1 | |
| SCHEMBL10783106 | 1.00 | ALDH1A1 (0.58) | ALDH1A1MAPK1L3MBTL1EPHX2TDP1 | |
| SCHEMBL6387083 | 1.00 | ALDH1A1 (0.58) | ALDH1A1MAPK1L3MBTL1EPHX2TDP1 | |
| SCHEMBL7095353 | 1.00 | ALDH1A1 (0.58) | ALDH1A1MAPK1L3MBTL1EPHX2TDP1 | |
| SCHEMBL15561335 | 1.00 | ALDH1A1 (0.58) | ALDH1A1MAPK1L3MBTL1EPHX2TDP1 | |
| SCHEMBL574387 | 1.00 | ALDH1A1 (0.58) | ALDH1A1MAPK1L3MBTL1EPHX2TDP1 | |
| SCHEMBL15561344 | 1.00 | ALDH1A1 (0.58) | ALDH1A1MAPK1L3MBTL1EPHX2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170183372-A1 | METHOD FOR PREPARING 6-AMINOHEXYL LACTOSIDE-NOTA CONJUGATE | Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C (TW) | 2017-06-29 | — | — | US | disclosed |
| EP-2360150-A1 | Method for the separation of intermediates which may be used for the preparation of escitalopram | H. Lundbeck A/S (DK) | 2011-08-24 | — | — | EP | disclosed |
| EP-1105399-B1 | CARBOXYLATED PHOSPHATIDIC ACID ESTERS | BRACCO RESEARCH SA (CH) | 2004-04-14 | — | — | EP | disclosed |
| US-6706280-B2 | DRUG TARGETING WITH LIPOSOMES AND MAGNETIC RESONANCE IMAGING CONTRAST MEDIA FOR DIAGNOSTICS | BRACCO RESEARCH S.A. (CH) | 2004-03-16 | — | — | US | disclosed |
| US-20020136760-A1 | CARBOXYLATED PHOSPHATIDIC ACID ESTERS | BRACCO RESEARCH S.A. (CH) | 2002-09-26 | — | — | US | disclosed |
| EP-1105399-A1 | CARBOXYLATED PHOSPHATIDIC ACID ESTERS | BRACCO RESEARCH S.A. (CH) | 2001-06-13 | — | — | EP | disclosed |
| WO-2000011007-A1 | CARBOXYLATED PHOSPHATIDIC ACID ESTERS | BRACCO RESEARCH S.A. (CH) | 2000-03-02 | — | — | WO | disclosed |
| WO-1999054344-A1 | COMPOSITION COMPRISING A COMBINATION OF DERIVATISED CATIONIC LIPOSOMES AND ACTIVE AGENT | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 1999-10-28 | — | — | WO | disclosed |
| US-3976660-A | Pyrrolidine derivatives | E. R. SQUIBB & SONS, INC. (US) | 1976-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170183372-A1 | METHOD FOR PREPARING 6-AMINOHEXYL LACTOSIDE-NOTA CONJUGATE | GNE, SI, B3GNT2 | ALDH1A1 972/4885MAPK1 3922/4885L3MBTL1 814/4885 |
| US-20020136760-A1 | CARBOXYLATED PHOSPHATIDIC ACID ESTERS | PHOSPHO1, PLD1, SGMS1 | ALDH1A1 1522/4885MAPK1 2643/4885L3MBTL1 1472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.